CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Agreement ended
- 8-K/A Event Other events
- 8-K/A Event Debt accelerated · Other events
- SC 13D/A Stake Beneficial Ownership Report
- 8-K/A Event Debt accelerated · Other events
- 8-K Event Debt accelerated · Other events
- 4 Other disposition Former Director, 10% holder disposed of 2,523,986 shares (other)
- 10-Q Report Quarterly Report
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- SC 13G Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
- S-3 Offering Registration Statement
Page 19 of 64 · 1,276 filings